SCHEMBL18409103

SCHEMBL18409103

CCc1cc(CNC(=O)C(F)F)c(F)cc1Nc1cc2c(ncn2C)c(NC(=O)C2CC2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 4/20 0.43
▸ JAK1 P23458 4/20 0.43
▸ JAK3 P52333 4/20 0.43
▸ TYK2 P29597 4/20 0.43
▸ TRPV1 Q8NER1 1/20 0.35
▸ IKBKB O14920 3/20 0.33
▸ GSK3B P49841 3/20 0.33
▸ DYRK1A Q13627 3/20 0.33
▸ CHUK O15111 2/20 0.33
▸ MAPK14 Q16539 2/20 0.33
▸ MAPK13 O15264 1/20 0.33
▸ CCNT1 O60563 2/20 0.31
▸ CDK4 P11802 2/20 0.31
▸ CCNA2 P20248 2/20 0.31
▸ CCND1 P24385 2/20 0.31
▸ CDK2 P24941 2/20 0.31
▸ CDK9 P50750 2/20 0.31
▸ RIPK1 Q13546 1/20 0.31
▸ RIPK3 Q9Y572 1/20 0.31
▸ KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398596 0.91 JAK2 (0.43) JAK2JAK1JAK3TYK2TRPV1
SCHEMBL18398598 0.85 TYK2 (0.47) JAK2JAK1JAK3TYK2TRPV1
SCHEMBL18409202 0.82 TYK2 (0.53) JAK2JAK1JAK3TYK2
SCHEMBL18409114 0.81 TYK2 (0.46) JAK2JAK1JAK3TYK2GSK3B
SCHEMBL18409108 0.78 JAK1 (0.47) JAK2JAK1JAK3TYK2GSK3B
SCHEMBL18409111 0.78 JAK2 (0.52) JAK2JAK1JAK3TYK2TRPV1
SCHEMBL18409102 0.77 LMNA (0.33) JAK2JAK1JAK3TYK2
SCHEMBL18398409 0.77 JAK1 (0.34) JAK2JAK1JAK3TYK2TRPV1
SCHEMBL18398581 0.76 JAK2 (0.53) JAK2JAK1JAK3TYK2GSK3B
SCHEMBL18409287 0.76 JAK2 (0.47) JAK2JAK1JAK3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback